Amid a busy earnings week, global markets have seen mixed results, with major indices like the Nasdaq Composite and S&P MidCap 400 experiencing record highs before pulling back. As growth stocks lag behind value shares due to cautious earnings reports from tech giants, investors are increasingly focusing on companies with strong insider ownership and robust earnings growth as potential opportunities.
Name | Insider Ownership | Earnings Growth |
Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3) | 17.3% | 21.1% |
Archean Chemical Industries (NSEI:ACI) | 22.9% | 34% |
Kirloskar Pneumatic (BSE:505283) | 30.3% | 26.3% |
Laopu Gold (SEHK:6181) | 36.4% | 33% |
Pharma Mar (BME:PHM) | 11.8% | 55.1% |
Alkami Technology (NasdaqGS:ALKT) | 11.2% | 98.6% |
Adveritas (ASX:AV1) | 21.2% | 144.2% |
Plenti Group (ASX:PLT) | 12.8% | 107.6% |
EHang Holdings (NasdaqGM:EH) | 32.8% | 81.4% |
Credo Technology Group Holding (NasdaqGS:CRDO) | 13.9% | 95% |
Let’s uncover some gems from our specialized screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Betsson AB (publ) operates an online gaming business through its subsidiaries, focusing on the Nordic countries, Latin America, Western Europe, Central and Eastern Europe, Central Asia, and other international markets with a market cap of approximately SEK19.56 billion.
Operations: The company’s revenue is primarily derived from its Casinos & Resorts segment, which generated €1.05 billion.
Insider Ownership: 10.8%
Earnings Growth Forecast: 16.8% p.a.
Betsson’s revenue is forecast to grow at 8.3% annually, outpacing the Swedish market, while earnings are expected to increase by 16.8%, also surpassing market growth. Despite a lack of substantial insider buying recently, insiders have purchased more shares than sold in the past three months. Betsson trades at a significant discount to its estimated fair value and offers good relative value compared to peers. Recent financial results showed increased sales but slightly lower net income year-over-year.
Simply Wall St Growth Rating: ★★★★★☆
Overview: LifeTech Scientific Corporation is an investment holding company that develops, manufactures, and trades interventional medical devices for cardiovascular and peripheral vascular diseases globally, with a market cap of approximately HK$7.83 billion.
Read More: 3 Growth Companies With High Insider Ownership And 29% Earnings Growth
